Health workers ’ perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso
Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15 –18 months of age) in Burkina Faso to help reduce meningococcal meningitis burde...
Source: BMC Public Health - Category: Consumer Health News Authors: Sylvain F. Nkwenkeu, Mohamed F. Jalloh, Jenny A. Walldorf, Robert L. Zoma, Felix Tarbangdo, Soukeynatou Fall, Sansan Hien, Roland Combassere, Cesaire Ky, Ludovic Kambou, Alpha Oumar Diallo, Akshaya Krishnaswamy, Flavien H. Ak é, Cynthia Hatcher, Jaymin C Tags: Research article Source Type: research
More News: Burkina Faso Health | Health | International Medicine & Public Health | Men | Meningitis | Meningitis Vaccine | Vaccines